Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-055032

Director sold 50,000 shares at $0.23 ($11,430)

  • Director acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kraus Al Director 2014-09-08 Option exercise +50,000 $0.04 $1,750 1,443,631 D
Kraus Al Director 2014-09-08 Sale −50,000 $0.23 $11,430 1,393,631 D
Derivatives
Kraus Al Director 2014-09-08 Option exercise · Stock Option −50,000 6,269,328 D
Open-market sales · 50,000 sh · avg $0.23 · $11,430
Loading xslF345X03/v388734_4.xml…